The content on this site is intended for healthcare professionals only
Changing dynamics of elderly myeloma patients
International Myeloma Workshop 2011 round up
Treatment of multiple myeloma at the Dana Faber Institute
Multiple Myeloma in the non-transplant setting (1/2)
Multiple Myeloma in the transplant setting (2/2)
Techniques to assess response to treatment and the management of bone disease in myeloma
Disease staging in myeloma and the implications for therapy
Flexible dosing of bortezomib for multiple myeloma
Lenalidomide and dexamethasone to delay progression of smouldering multiple myeloma
International Myeloma Workshop highlights and ongoing IMF studies
Lenalidomide survival benefit as continuous therapy for multiple myeloma
Tailoring therapy in elderly myeloma patients
